|
Volumn 13, Issue 2, 2011, Pages
|
Response to 'Effect of etanercept in polymyalgia rheumatica: A randomized controlled trial'
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
C REACTIVE PROTEIN;
DICLOFENAC;
ETANERCEPT;
INTERLEUKIN 6;
LEFLUNOMIDE;
PREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
TUMOR NECROSIS FACTOR RECEPTOR;
AGED;
ANKYLOSING SPONDYLITIS;
CASE REPORT;
CLINICAL FEATURE;
DISEASE COURSE;
DRUG DOSE REDUCTION;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HUMAN;
IMMUNOPATHOLOGY;
LETTER;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RHEUMATIC POLYMYALGIA;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
MALE;
NOTE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
POLYMYALGIA RHEUMATICA;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
EID: 79954599129
PISSN: 14786354
EISSN: 14786362
Source Type: Journal
DOI: 10.1186/ar3269 Document Type: Letter |
Times cited : (8)
|
References (5)
|